rabbit anti ezh2 Search Results


anti-ezh2  (US Biological Life Sciences)
90
US Biological Life Sciences anti-ezh2
Anti Ezh2, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+ezh2/pm24726732-99-19-22?v=US+Biological+Life+Sciences
Average 90 stars, based on 1 article reviews
anti-ezh2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
polyclonal rabbit anti-ezh2  (Bioworld Antibodies)
90
Bioworld Antibodies polyclonal rabbit anti-ezh2
<t> EZH2 </t> and HDAC1/2 expression in PTCL.
Polyclonal Rabbit Anti Ezh2, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+ezh2/pmc06607380-241-41-49?v=Bioworld+Antibodies
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-ezh2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
rabbit anti- ezh2 polyclonal antibody  (Cusabio)
N/A
Rabbit anti-Human EZH2 Polyclonal Antibody
   Buy from Supplier
anti-kmt6 / ezh2 rabbit monoclonal antibody  (Boster Bio)
N/A
Boster Bio Anti-KMT6 / EZH2 Rabbit Monoclonal Antibody catalog # M00050. Tested in WB application. This antibody reacts with Human.
   Buy from Supplier
rabbit anti ezh2 polyclonal affinity purified  (Innovative Research Inc)
N/A
Rabbit Anti EZH2 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4) (Western Blot) from Innovative Research is a polyclonal antibody in a liquid format, buffered in PBS with 0.02%
   Buy from Supplier
rabbit anti-human ezh2 polyclonal antibody  (Cusabio)
N/A
Rabbit anti-Human EZH2 Polyclonal Antibody
   Buy from Supplier
rabbit anti-human ezh2 (n-terminus)  (RayBiotech)
N/A
EZH2 Rabbit anti-Human Polyclonal (N-Terminus) (Unconjugated) Antibody, (50 µg)
   Buy from Supplier
rabbit anti-human ezh2  (RayBiotech)
N/A
Rabbit Anti-Human EZH2 Antibody, 400 µl
   Buy from Supplier

Image Search Results


EZH2 and HDAC1/2 expression in PTCL.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: EZH2 and HDAC1/2 expression in PTCL.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing

Representative immunohistochemical features of HDAC1 (left), HDAC2 (middle), and EZH2 (right) in PTCL-NOS, ALCL, NK/T and AITL. All images were captured at ×200 and ×400 magnifications. HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2; PTCL-NOS, peripheral T cell lymphoma not otherwise specified; ALCL, anaplastic large cell lymphoma; NK/T, natural killer/T-cell; AITL, angioimmunoblastic T-cell lymphoma.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: Representative immunohistochemical features of HDAC1 (left), HDAC2 (middle), and EZH2 (right) in PTCL-NOS, ALCL, NK/T and AITL. All images were captured at ×200 and ×400 magnifications. HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2; PTCL-NOS, peripheral T cell lymphoma not otherwise specified; ALCL, anaplastic large cell lymphoma; NK/T, natural killer/T-cell; AITL, angioimmunoblastic T-cell lymphoma.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Immunohistochemical staining, Histone Deacetylase Assay

Correlations between EZH2 and HDAC1/2 in four subtypes of PTCL.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: Correlations between EZH2 and HDAC1/2 in four subtypes of PTCL.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques:

Correlations between EZH2/HDAC1/2 expression and the clinicopathological characteristics in PTCL.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: Correlations between EZH2/HDAC1/2 expression and the clinicopathological characteristics in PTCL.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing

Correlations between the EZH2/HDAC1/2 expression and the clinicopathological characteristics in PTCL-NOS.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: Correlations between the EZH2/HDAC1/2 expression and the clinicopathological characteristics in PTCL-NOS.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing

Correlations between the EZH2/HDAC1/2 expression and the clinicopathological characteristics in NK/TCL.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: Correlations between the EZH2/HDAC1/2 expression and the clinicopathological characteristics in NK/TCL.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing

OS rates based upon the expression levels of EZH2 and HDAC1/2 in PTCL. (A) Significant trend towards poorer OS rates for patients with high EZH2 expression (P=0.012). (C) High expression of HDAC2 was correlated with a poorer OS rate compared with low expression of HDAC2 (P<0.001), which was not observed in the HDAC1 group [(B); P=0.353]. OS, overall survival; HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: OS rates based upon the expression levels of EZH2 and HDAC1/2 in PTCL. (A) Significant trend towards poorer OS rates for patients with high EZH2 expression (P=0.012). (C) High expression of HDAC2 was correlated with a poorer OS rate compared with low expression of HDAC2 (P<0.001), which was not observed in the HDAC1 group [(B); P=0.353]. OS, overall survival; HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing, Histone Deacetylase Assay

OS based upon the levels of EZH2 and HDAC1/2 in PTCL-NOS. (A) Significant trend towards poorer OS rates for patients with high EZH2 (P=0.002). (C) High expression of HDAC2 was correlated with a poorer OS rate, compared with low expression of HDAC2 (P<0.001), which was not observed in the HDAC1 group [(B); P=0.339]. OS, overall survival; HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2; PTCL-NOS, peripheral T cell lymphoma not otherwise specified.

Journal: Oncology Letters

Article Title: Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma

doi: 10.3892/ol.2019.10410

Figure Lengend Snippet: OS based upon the levels of EZH2 and HDAC1/2 in PTCL-NOS. (A) Significant trend towards poorer OS rates for patients with high EZH2 (P=0.002). (C) High expression of HDAC2 was correlated with a poorer OS rate, compared with low expression of HDAC2 (P<0.001), which was not observed in the HDAC1 group [(B); P=0.339]. OS, overall survival; HDAC, histone deacetylase; EZH2, enhancer of zeste homolog 2; PTCL-NOS, peripheral T cell lymphoma not otherwise specified.

Article Snippet: Following rinsing with phosphate-buffered saline, the slides were incubated with polyclonal rabbit anti-HDAC1 (catalog no. BS6485; 1:100 dilution; Bioworld Technology, Inc., St. Louis Park, MN, USA), polyclonal rabbit anti-HDAC2 (catalog no. 12922-3-AP; 1:200 dilution; ProteinTech Group, Inc., Chicago, IL, USA) and polyclonal rabbit anti-EZH2 (catalog no. BS90776; 1:50 dilution; Bioworld Technology, Inc.) primary antibodies overnight at 4°C.

Techniques: Expressing, Histone Deacetylase Assay